SFRP4 linked to impaired glucose tolerance, T2DM

August 1, 2016

(HealthDay)—Secreted frizzled-related protein 4 (SFRP4) is associated with impaired glucose tolerance (IGT) and type 2 diabetes (T2D), according to a report published online July 6 in Diabetes Care.

Kaviya Anand, from the Madras Diabetes Research Foundation in Chennai, India, and colleagues reported on the systemic levels of SFRP4 and its correlation with and β-cell dysfunction in 100 individuals with normal (NGT), 60 with IGT, and 100 with T2D.

The researchers found that circulatory SFRP4 levels were highest in T2D, followed by IGT and NGT (57 ± 7 ng/mL; 40 ± 4 ng/mL; and 27 ± 2 ng/mL, respectively). There were positive correlations between SFRP4 levels and age, homeostatic model assessment-insulin resistance, fasting , fasting insulin, glycated hemoglobin, and serum triglycerides; an inverse correlation was seen for the oral disposition index (DIo). After adjustment for age, sex, waist circumference, glycated hemoglobin, and DIo, higher levels of SFRP4 were independently associated with IGT and T2D (odds ratios per standard deviation, 1.39 and 2.62, respectively).

"These findings suggest that elevated SFRP4 may be a good marker of β-cell dysfunction and insulin resistance," the authors write. "Longitudinal studies with serial measurements of SFRP4 need to be done at different stages of insulin resistance, IGT, and T2D to understand the precise pathophysiological mechanisms involved."

Explore further: Insulin resistance ups T2D risk, independent of BMI

More information: Full Text

Related Stories

Insulin resistance ups T2D risk, independent of BMI

July 7, 2014
(HealthDay)—A genetic score for insulin resistance is associated with lower body mass index (BMI) and with incident type 2 diabetes (T2D) even among individuals of normal weight, according to a study published online June ...

Circulating MicroRNAs linked to type 2 diabetes

February 7, 2014
(HealthDay)—Circulating microRNAs (miRNAs) are associated with type 2 diabetes (T2D), and their levels vary with insulin action, according to a study published online Jan. 29 in Diabetes Care.

Selective biomarkers can ID risk of impaired glucose tolerance

April 8, 2016
(HealthDay)—Selective biomarkers can identify the risk of isolated impaired glucose tolerance (iIGT), according to a study published online April 5 in Diabetes Care.

Ferritin, transferrin positively linked to type 2 diabetes

February 18, 2016
(HealthDay)—Higher levels of ferritin and transferrin correlate with increased risk of type 2 diabetes (T2D) among men and women, according to a study published online Feb. 9 in Diabetes Care.

Sleep-disordered breathing in REM linked to insulin resistance

November 5, 2015
(HealthDay)—The correlation between sleep-disordered breathing (SDB) and glucose metabolism varies for rapid eye movement (REM) sleep and non-REM sleep, according to a study published in the Nov. 1 issue of the American ...

Protein reveals diabetes risk many years in advance

November 7, 2012
When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who ...

Recommended for you

Bariatric surgery successes lead to type 2 diabetes treatment

April 24, 2018
Bariatric surgery has long yielded almost immediate health benefits for patients with type 2 diabetes, and new findings on the reasons for remission may be the key to developing drug alternatives to surgery.

Hacking human 'drug trafficking' network could make diabetes treatments more effective

April 23, 2018
Making tiny changes to existing diabetes treatments can alter how they interact with cells, and potentially make the medicines more effective.

Vitamin D deficiency linked to greater risk of diabetes

April 19, 2018
An epidemiological study conducted by researchers at University of California San Diego School of Medicine and Seoul National University suggests that persons deficient in vitamin D may be at much greater risk of developing ...

One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo

April 17, 2018
One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo, suggests new findings.

People with Type 2 diabetes who eat breakfast later, more likely to have a higher BMI

April 16, 2018
Being an "evening person" is linked to higher body mass indices among people with Type 2 diabetes, and having breakfast later in the day seems to be what drives this association, according to a new paper in the journal Diabetic ...

Continuous glucose monitors proven cost-effective, add to quality of life for diabetics

April 12, 2018
Continuous glucose monitors (CGM) offer significant, daily benefits to people with type 1 diabetes, providing near-real time measurements of blood sugar levels, but they can be expensive. A new study by researchers from the ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.